Acceder

Juan Antonio Vílchez Aguilera

Buscador

Rivera-Caravaca JM, Vílchez JA, Rodríguez-Rojas C, Albadalejo-Otón MD, Gil-Pérez P, Lopez-García C, Veliz-Martínez A, Roldán V, Marín F. Influence of the matrix type over the concentration of GDF-15. J Investig Med. 2020 Sep 8. pii: jim-2020-001351. doi: 10.1136/jim-2020-001351. [Epub ahead of print] PubMed PMID: 32907909.
AÑO: 2020; IF: 2.304
Rivera-Caravaca JM, Marín F, Vilchez JA, Gálvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldán V. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14. PubMed PMID: 31084333.
AÑO: 2019; IF: 6.046
Hernández-Romero D, Sánchez-Quiñones J, Vílchez JA, Rivera-Caravaca JM, de la Morena G, Lip GYH, Climent V, Marín F. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. Sci Rep. 2019 Apr 17;9(1):6235. doi: 10.1038/s41598-019-42727-4. PubMed PMID: 30996283; PubMed Central PMCID: PMC6470309.
AÑO: 2019; IF: 4.011
Romero-Cara P, Torres-Moreno D, Pedregosa J, Vílchez JA, García-Simón MS, Ruiz-Merino G, Morán-Sanchez S, Conesa-Zamora P. A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. Int J Med Sci. 2018 Jan 1;15(1):10-15. doi: 10.7150/ijms.22812. eCollection 2018. PubMed PMID: 29333082; PubMed Central PMCID: PMC5765734.
AÑO: 2018; IF: 2.284
Hernández-Romero D, Vílchez JA, Lahoz Á, Romero-Aniorte AI, Jover E, García-Alberola A, Jara-Rubio R, Martínez CM, Valdés M, Marín F. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation. Sci Rep. 2017 Jan 12;7:40378. doi: 10.1038/srep40378. PubMed PMID: 28079145; PubMed Central PMCID: PMC5228133.
AÑO: 2017; IF: 4.122

Instituto de Investigación Sanitaria Acreditado

ISCII